1. Home
  2. NXPL vs CPIX Comparison

NXPL vs CPIX Comparison

Compare NXPL & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$9.08

Market Cap

24.3M

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$6.48

Market Cap

98.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXPL
CPIX
Founded
1997
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
98.3M
IPO Year
2011
2007

Fundamental Metrics

Financial Performance
Metric
NXPL
CPIX
Price
$9.08
$6.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.6K
66.6K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
58.70
EPS
N/A
N/A
Revenue
$5,869,558.00
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.50
16.75
52 Week Low
$0.34
$1.85
52 Week High
$9.94
$9.28

Technical Indicators

Market Signals
Indicator
NXPL
CPIX
Relative Strength Index (RSI) 60.08 39.53
Support Level $5.54 $5.55
Resistance Level $9.94 $8.27
Average True Range (ATR) 0.60 0.62
MACD -0.11 -0.20
Stochastic Oscillator 24.92 6.25

Price Performance

Historical Comparison
NXPL
CPIX

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: